Monsanto looks to benevolent bacteria for its next breakthrough

Infamous for its genetically modified crops and monopoly-like control of the North American seed market, Monsanto is taking a rather more positive step this week with the announcement of a partnership with Danish research lab Novozymes. Monsanto will pay Novozymes $ 300 million up front to kickstart what the two companies are calling the BioAg Alliance, a joint venture for the discovery and development of microorganisms that can enhance plant fertility and disease resistance.

Continue reading…

The Verge – All Posts

Leave a Comment